Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Dec 12, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000051.pdf 0001968202-23-000051.xls
Dec 12, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000090.pdf 0001883850-23-000090.xls
Dec 12, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000091.pdf 0001883850-23-000091.xls
Dec 12, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000088.pdf 0001883850-23-000088.xls
Dec 12, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000089.pdf 0001883850-23-000089.xls
Dec 11, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-005844.pdf 0001950047-23-005844.xls
Dec 06, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000046.pdf 0001968202-23-000046.xls
Dec 05, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001973141-23-000328.pdf
Dec 04, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000044.pdf 0001968202-23-000044.xls
Nov 15, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000042.pdf 0001968202-23-000042.xls

Data provided by Kaleidoscope.

Investors & Media